Image Credit: Canva
When was the last time you measured your waistline? If you assume that BMI is the only number to focus on when it comes to your health, think twice. New research has revealed a shocking revelation—your waist circumference might be a far better predictor of men's cancer risk than BMI.
The study finds that for each 4-inch increase in waist size, a man's risk of cancer increases by a staggering 25%. Meanwhile, BMI, commonly regarded as the gold standard for assessing obesity, raises cancer risk by only 19% for the same weight gain. So, if you've been dismissing that pesky belly fat, it's time to take notice.
But why is your waistline so important? The reason is visceral fat—the hidden, deep fat that accumulates around your organs. Unlike other body fat, visceral fat is a stealthy troublemaker, causing inflammation, insulin resistance, and abnormal blood fat levels—all of which combine to create a cancer-perfect storm.
Obesity has been associated with an increased risk of numerous health conditions, including cancer, for decades. The research, though, indicates that a specific measure of the body—waist circumference—may be an even more reliable forecaster of cancer risk in men than the more frequently employed Body Mass Index (BMI). This finding emphasizes the need to pay particular attention to the distribution of fat and not merely to the weight of the body.
BMI has been the go-to measure for years for gauging health risks related to obesity. New research, though, that appears in The Journal of the National Cancer Institute indicates that waist measurement is a better predictor of cancer risk in men. According to the research, four more inches (10 cm) around the waist will add 25% to a man's cancer risk. Conversely, a 3.7 kg/m² rise in BMI (from a BMI of 24 to 27.7) increased cancer risk by only 19%.
Why is waist circumference a better predictor, then? Unlike BMI, which measures weight relative to height, waist circumference actually measures abdominal fat—specifically, visceral fat. This type of fat encircles internal organs and is also linked to higher levels of inflammation, insulin resistance, and abnormal blood lipids, all of which are factors in cancer growth. BMI, however, does not measure fat distribution, so two individuals with the same BMI can have very different levels of health risk depending on where fat is deposited on their bodies.
Interestingly, the research identified a significant difference between men and women when it came to waist circumference and cancer risk. Although waist circumference and BMI were linked with obesity-related cancers in women, the relationship was weaker than for men. An increase of 12 cm (4.7 inches) in waist size or a 4.3 rise in BMI (from 24 to 28.3) raised the cancer risk in women by just 13%—a much lower percentage than for men.
Experts credit this difference to the way that fat is stored in the body. Men are more likely to carry fat around the abdomen, especially as visceral fat, which is more metabolically active and associated with cancer-producing biological alterations. Women, by contrast, store fat in peripheral sites such as the hips and thighs, where it is less likely to drive systemic inflammation and metabolic disturbances.
A possible reason is that men tend to depot fat more in the visceral regions, whereas women tend to carry more subcutaneous and peripheral fat," wrote the researchers. "This may render waist circumference a more robust risk factor for cancer in men and account for why waist circumference provides additional risk information beyond BMI in men but not women."
The research used the International Agency for Research on Cancer (IARC) data to define obesity-related cancers. These cancers are esophageal (adenocarcinoma), gastric (cardia), colorectal, rectal, liver, gallbladder, pancreatic, renal, and thyroid cancers, and multiple myeloma and meningioma. In men, abdominal obesity is especially significant in raising the risk of these cancers through high levels of insulin and markers of inflammation.
For women, the research proposes that both waist circumference and hip circumference may give a more accurate estimate of visceral fat and cancer risk. "Adding hip circumference to risk models could strengthen the link between waist circumference and cancer, especially in women," researchers observed.
With these results, doctors advise men to be more mindful of their waistline than only their BMI. Waist size is an easy method to gauge health risk, and its maintenance through lifestyle changes might be the key to cancer prevention.
Track Your Waist Size: Regularly measure your waist circumference and try to keep it in a healthy range (below 40 inches for men, according to medical advice).
Eat a Balanced Diet: A diet containing high fiber, lean protein, and healthy fats can assist in limiting visceral fat gain.
Exercise Consistently: Regular exercise with a combination of aerobic and strength training will help maintain a healthy waistline.
Control Stress and Sleep: Persistent stress and inadequate sleep tend to cause weight gain, especially in the midsection of the body.
Regular Health Screenings: Early identification of cancer risk factors through regular screening can greatly enhance long-term health status.
Credit: Canva
A team of US researchers has developed a novel nasal swab test, akin to those used to detect COVID-19 infections, which can spot early signs of Alzheimer's Disease -- affecting over 55 million people worldwide.
The condition is treatable in early stages to manage symptoms and slow cognitive decline. However, it remains the hardest to detect, affecting treatment outcomes. The brain changes can begin 10 to 20 years before symptoms become apparent.
The novel outpatient nasal swab, developed by Duke University researchers, has shown promise in picking up early biological changes linked to Alzheimer's. It can spot the degenerative condition, even before problems related to thinking and memory begin to appear.
"We want to be able to confirm Alzheimer's very early, before damage has a chance to build up in the brain," said Bradley J. Goldstein, professor at Duke University's School of Medicine.
"If we can diagnose people early enough, we might be able to start therapies that prevent them from ever developing clinical Alzheimer's," Goldstein added.
In the study, published in the journal Nature Communications, the team placed a gentle swab high inside the nose of 22 participants.
The swab collected thousands of nerve and immune cells to see which genes are active.
The analysis clearly differentiated people with early or diagnosed Alzheimer's from those without the disease -- 81 percent of the time. It also included people with no symptoms.
Alzheimer's disease is one of the most common forms of dementia and mostly affects adults over the age of 65.
About 8.8 million Indians aged 60 and above are estimated to be living with Alzheimer's disease. Over seven million people in the US, 65 and older, live with the condition, and over 100,00 die from it annually.
Alzheimer's disease is believed to be caused by the development of toxic amyloid and beta proteins in the brain, which can accumulate and damage cells responsible for memory.
While there is no clear cause of Alzheimer's disease, experts believe it can develop due to genetic mutations and lifestyle choices, such as physical inactivity
unhealthy diet
social isolation.
Early symptoms of Alzheimer's disease include forgetting recent events or conversations. Other signs include:
Over time, Alzheimer's disease leads to serious memory loss and affects a person's ability to do everyday tasks.
Currently, there is no cure for this progressive brain disorder, and in advanced stages, loss of brain function can cause dehydration, poor nutrition, or infection. These complications can result in death.
Being physically active and taking part in activities and social interactions that stimulate the brain and maintain daily function can help prevent the condition.
Credit: iStock
Heart diseases are viewed as a universal health concern, and advancements in cardiology have hugely improved diagnosis and treatment outcomes around the world. At the same time, emerging research is shedding more light on how cardiovascular disease affects women.
In India, this perspective is especially important. Of the more than 10 million deaths recorded annually in the country, nearly two million are attributed to diseases of the circulatory system, with women accounting for about 40% of these cases. Significantly, more than half of the nearly 800,000 cardiovascular deaths among Indian women each year occur prematurely, underscoring the importance of greater awareness, early detection, and timely medical care.
It is evident that modern cardiology has been shaped by the findings from large, well-characterized populations of patients. The frameworks that have been established from such findings are the ones that guide the approaches that are currently used in the diagnosis and treatment of various forms of heart disease.
Such frameworks have been instrumental in the advancement of the management of various forms of cardiovascular diseases worldwide. As the research expands to include larger populations, there is an increased understanding that the manifestation of cardiovascular diseases differs from one group to another, particularly in females.
This growing awareness is particularly useful in recognizing symptoms. Although women, like men, may experience chest pain as a symptom of a heart attack, there are other, less common symptoms that women may also experience.
These include fatigue, shortness of breath, nausea, dizziness, as well as neck, jaw, or back discomfort. The awareness of these symptoms will allow women to seek treatment sooner, as well as help healthcare providers better understand their symptoms.
Women’s heart health is influenced by various life stages and the hormonal changes that accompany them. For instance, after menopause, estrogen levels decline, and since this hormone offers some protective benefits for the heart, the risk of developing heart disease may gradually rise.
Certain pregnancy-related conditions, including gestational diabetes, preeclampsia, and high blood pressure during pregnancy, may also indicate a greater likelihood of cardiovascular disease later in life. Recognising these factors allows doctors to monitor heart health more closely and recommend preventive measures that support long-term wellbeing.
Prevention continues to be one of the most effective strategies for reducing heart disease. Regular health check-ups, along with monitoring blood pressure, cholesterol, and blood sugar, are essential for lowering cardiovascular risk. Adopting healthy lifestyle habits further supports long-term heart health. Awareness is equally important.
Symptoms such as fatigue or breathlessness are not always immediately linked to heart disease, particularly among women. Raising awareness about heart health can help people recognize early warning signs sooner and seek timely care.
Encouragingly, the field of cardiology is constantly evolving with the help of emerging research that is further enlightening us about the health of the heart in both men and women. With more women being included in research and better developments in diagnostic procedures, healthcare professionals are refining their strategies to deal with heart health.
Thus, by adopting the best strategies and emerging research about the health of women’s hearts, awareness and early intervention are the keys to better outcomes and reduced risks among women in India.
Credits: Canva
The recent deaths of two young people and more than a dozen confirmed cases have brought meningitis back into the public conversation in the United Kingdom. According to Prof Devi Sridhar, chair of global public health at the University of Edinburgh, who wrote for The Guardian the situation is concerning but also a reminder of how public health systems and vaccination programmes shape disease patterns.
Sridhar explains that meningitis has long been a serious public health concern. In the 1990s, the UK recorded around 2,500 laboratory confirmed cases of meningococcal disease each year. Most of these were caused by meningococcal group C bacteria. When the MenC vaccine was introduced in 1999, cases linked to that strain dropped dramatically, falling by about 96 percent to just a few dozen cases annually. Later, vaccination programmes expanded to include the ACWY strains, which also helped reduce infections by limiting transmission.
Another factor behind the current rise is the unusual drop in cases during the COVID-19 pandemic. As Sridhar notes, restrictions on social mixing and other preventive measures in 2020 caused meningitis cases to fall to historic lows, with only about 80 confirmed cases in England that year. Since then, the numbers have gradually increased as normal social activity returned.
Read: Meningitis Outbreak: How to Differentiate The Symptoms From a Common Rash
Sridhar points out that a different strain of bacteria, known as MenB, is now responsible for most recent cases, particularly among younger people. The MenB vaccine was added to the routine childhood immunization programme in 2015, but it only protects children born after that year. Many teenagers and university students therefore remain unvaccinated against this strain.
Read: Meningitis Outbreak: University of Kent Student Among Two Who Died of the ‘Invasive’ Disease
University environments can also contribute to outbreaks because meningitis spreads through close contact such as coughing, sneezing, kissing or sharing items like vapes. According to Sridhar, public health teams respond by tracing close contacts, providing antibiotics, monitoring symptoms and offering targeted vaccinations.
In Kent, authorities have launched a ring vaccination programme focusing on university students to contain the spread. Sridhar says such measures highlight the continued importance of strong public health systems and sustained investment in vaccination programmes to prevent future outbreaks.
Meningitis is a serious medical condition that affects the protective membranes covering the brain and spinal cord, the meninges. While fever is not always present, it is usually considered as one of the classic symptoms of meningitis. It is important to know the varied symptoms, causes, and treatments of meningitis for early diagnosis and proper management of the disease.
Meningitis is an infectious illness that brings about inflammation in the meninges. The most common cause of such inflammation is bacterial or viral infections, though other causes are also possible including fungal, parasitic, or non-infectious causes (autoimmune disease, head injury, or brain surgery). Meningitis may be caused by bacterial meningitis, which the Centers for Disease Control and Prevention (CDC) indicates can be so severe and bring about conditions like hearing loss, vision problems, and death if not received on time.
© 2024 Bennett, Coleman & Company Limited